.@CreavoMedTech has announced the appointment of Martin Frost as Chairman. Martin will drive Creavo’s #fundraising plans, and guide its strategy to scale the business and commercialise its #diagnostic technologies. Read more here:

.@ersgenomics have today announced the appointment of Michael Arciero as VP Intellectual Property & Corporate Development. Read the full announcement here: #intellectualproperty

.@OXGENEofficial today announced the launch of its scalable, plasmid-free manufacturing system for AAV - TESSA Technology. The novel technology provides a solution to the challenges faced by traditional approaches of AAV manufacturing. Read more here:

.@OwlstoneMedical today announced the results of a patient study that validates the Company's #EVOC probe strategy for the development of breath-based diagnostic & prognostic tests for #NAFLD & #NASH. Read more here: #limonene #breathbiopsy

Load More